Clinical Trial Update: Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

View source ↗

Summary

A completed clinical trial comparing progesterone-primed ovarian stimulation to GnRH antagonist protocols in women with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• GnRH antagonist protocol (Gonadotropin-releasing hormone antagonist protocol)
• Progesterone Primed Ovarian Stimulation

Snippet

Sponsor: El Shatby University Hospital for Obstetrics and Gynecology | Conditions: Controlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome | Status: COMPLETED